Funds Disclosing Short Positions. TYME: Get the latest Tyme Technologies stock price and detailed information including TYME news, historical charts and realtime prices. “$TYME to host live conference call webcast today, June 10, 2021, at 5:00 PM ET. Find out what this means to you and get the rest of the rankings on TYME! Tyme Technologies Inc also achieved a score of 66 in the Biotechnology industry, putting it above 66 percent of Biotechnology stocks. Tyme Technologies Inc NASDAQ Updated Jun 14, 2021 11:13 PM. . In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. Get the hottest stocks to trade every day before the market opens 100% free. Interested parties can register for or listen to the call using this link. These shares were sold in multiple transactions at prices ranging from $1.4300 to $1.4350 inclusive. The stock's lowest day price was 1.38. TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET Posted on 05/26/2021 231 History; Forecast; Charts; Data; Market; Q&A; Comments; Buy TYME > Page 1: Tyme Technologies Inc (TYME) Forecast Charts . Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. TYME-18 is distinct in composition from SM-88. Form 4 filed by Tyme Technologies, Inc. with the security and exchange commission. 26.05.2021 - TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based … Tyme Technologies Names Frank Porfido Chief Financial Officer >TYME May. Tyme Technologies Inc (NASDAQ:TYME) continues to move higher in the pre-market session. TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET May 26, 2021 TYME Appoints Frank L. Porfido as Chief Financial Officer Tyme Technologies Continues To Anticipate Its Qtrly Cash Usage Will Average Between $7-8 Million 2021. Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results June 10, 2021 4:17 PM Download this Press Release PDF Format (opens in new window) In February, Tyme Bank raised $109m. Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results Jun 10 2021 TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET May 26 2021 Tyme Technologies, Inc., a clinical-stage biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Start Time: 5:00 PM EDT. Tyme Technologies, Inc. earnings are expected to increase by 40.4% in 2021, but the outlook is negative 0% per year for the next five years. Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results Jun 10 2021; TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET May 26 2021; TYME Appoints Frank L. Porfido as Chief Financial Officer May 13 2021 TYME. Tyme Technologies stock is trading at 1.43 as of the 14th of June 2021, a -2.05 percent decrease since the beginning of the trading day. 24 talking about this. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. Solid Liquidity Position. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is … Volume has increased on the last day by 3 million shares but on falling prices. Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsâ¢), announced that management will present at the 2020 Cross-Border Healthcare Webinar Series on Tuesday, April 7, 2020. The Company will present its corporate overview with a focus on: 11 talking about this. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. May 26, 2021 TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10 (th) at 5:00 PM ET PR Newswires. TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET Posted on 05/26/2021 231 You can read further details here Bedminster, New Jersey 07921. Tyme Technologies Inc (TYME) stock is trading at $1.58 as of 9:53 AM on Tuesday, Jun 1, a rise of $0.04, or 2.6% from the previous closing price of $1.54. TYME-18 is a pre-clinical CMBT compound under development that is delivered intratumorally. Free Report Louis Navellier's Top 6 Stocks for 2021 Tyme Technologies, Inc. and Subsidiaries Consolidated Statements of Operations Years Ended March 31, 2021 2020 Operating expenses: Research and development $ 17,031,474 Tyme Technologies June 13, 2021 Opportunity Range. 127. Looking at the companyâs year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. Tyme Inc. Dr. Van Tornout brings over 25 years of medical experience in academia and industry, including over 15 years of global drug development in pharmaceutical and biotech settings and encompassing preclinical, IND, FIH, phase II-IV, (s)NDA, BLA, safety, medical affairs, clinical operations and regulatory experience. Recently in News on May 26, 2021, TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET. Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results. Volume today is less active than usual. Tyme Technologies currently holds about 13.49 M in cash with (24.2 M) of positive cash flow from operations. . Shares of Tyme Technologies ( NASDAQ:TYME) were skyrocketing 84.9% higher as of 12:09 p.m. EST on Wednesday after rising as much as 174% earlier in … Along with financial statement analysis, the daily predictive indicators of Tyme Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tyme Technologies. TYME Technologies, Inc. is an emerging biotechnology company developing cancer metabolism-based therapies that are intended to be broadly effective across ⦠Sector Health Care/Life Sciences. Tyme Technologies 's earnings in 2021 is -$28,978,763.On average, 1 Wall Street analysts forecast TYME's earnings for 2022 to be $-34,441,379, with the lowest TYME earnings forecast at $-34,441,379, and the highest TYME Tyme Technologies, Inc. (Nasdaq:TYME) (the "Company" or "TYME"), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today reported its conclusions from its recently conducted comprehensive strategic review and its fourth quarter and fiscal year 2021 … TYME and its employees are working relentlessly to discover, develop and deliver innovative disease-altering medicines. Press question mark to learn the rest of the keyboard shortcuts Looking at ⦠The stock price fluctuated between $1.285 and $1.4154 throughout the trading session with the volume trading being 3649291 shares, which represented a significant variation when compared to the three months average volume ⦠About TYME Technologies, Inc. TYME Technologies, Inc. is an emerging biotechnology company developing cancer metabolism-based 2. Tyme Technologies will be holding an earnings conference call on Thursday, June 10th. TYME-18 is a combination of a proprietary surfactant system and natural sulfonic/bile acid that is designed to disrupt energy metabolism and have lytic function for potential treatment of inoperable tumors. Tyme Technologies Inc (NASDAQ: TYME) announced a breast cancer trial with Georgetown University named OASIS.Enrollment is expected to start in Q3 of 2021. Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Lets a quick look at companyâs past reported and future predictions of growth We are focusing on metastatic and hard-to-treat cancers for which current therapies are inadequate. TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET. Looking at the companyâs year-over-year earnings, the past five years showed a negative earnings growth rate of 0%. Tyme Technologies Inc insider trades are shown in the following chart. Roughly 37.0% of the company outstanding shares are owned by corporate insiders. Tyme Technologies, Inc. and Subsidiaries. Shares of Tyme Technologies soared as much as 127% on Wednesday. TYME has an Overall Score of 42. 24 talking about this. Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results Reply Replies (2) 5 1 The company report on May 13, 2021 that TYME Appoints Frank L. Porfido as Chief Financial Officer. At TYME we are committed to conquering advanced cancers! You can read further details here Issuer Name and Ticker or Trading Symbol TYME TECHNOLOGIES, INC. [TYME] (Last) (First) (Middle) C/O TYME TECHNOLOGIES, INC., 1 PLUCKEMIN WAY - SUITE 103 Stock Predictons by days: 2021 Search Stock, FX pair, Crypto, or Commodity... Tyme Technologies Inc Stock Forecast and Price Prognosis Data for 2021 Intraday shares traded counted 3.73 million, which was … 1. Press Release reported on 05/13/21 that TYME Appoints Frank L. Porfido as Chief Financial Officer. Tyme Technologies, Inc. and Subsidiaries Consolidated Statements of Operations Years Ended March 31, 2021 2020 Operating expenses: Research and development $ 17,031,474 $ ⦠Tyme Technologies, Inc. (NASDAQ:TYME) with the stream of 0.16% stocksequity 4 days ago TYME Announces Abstract Selected for Publication at the 2021 American Society of Clinical Oncology Annual Meeting Tyme Technologies Inc. (NASDAQ:TYME) traded at $1.30 at last check on Tuesday, June 15, made a downward move of -9.09% on its previous dayâs price. Tyme Technologies Inc. [NASDAQ: TYME] slipped around -0.1 points on Tuesday, while shares priced at $1.33 at the close of the session, down -6.99%. The price reported in Column 4 is a weighted average price. View as PDF. The following slide deck was published by Tyme Technologies, Inc. in conjunction with their 2021 Q4 earnings call. Date of Event Requiring Statement (Month/Day/Year) 04/01/2021: 3. The Tyme Technologies Inc stock price fell by -5.66% on the last day (Friday, 11th Jun 2021) from $1.59 to $1.50.During the day the stock fluctuated 15.38% from a day low at $1.43 to a day high of $1.65.The price has fallen in 6 of the last 10 days, but is still up by 1.35% over the past 2 weeks. Operating expenses: Research and development Market Reaction As of 7:02, TYME is up 3.14% to $1.64 with 134K shares traded hands. Tyme Technologies Inc. analyst estimates, including TYME earnings per share estimates and analyst recommendations. The TYME stockâs 52-week price range has touched low of $0.85 and a $4.99 high. The institutional investor bought 2.5 million shares of the stock in a transaction took place on 3/31/2021. TYME and its employees are working relentlessly to discover, develop and deliver innovative disease-altering medicines. Issuer Name and Ticker or Trading Symbol TYME TECHNOLOGIES, INC. [ TYME] 4. ⦠Tyme Technologies Inc is around the middle of the Biotechnology industry according to InvestorsObserver.TYME received an overall rating of 41, which means that it scores higher than 41 percent of all stocks. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. TYME Technologies, Inc. is an emerging biotechnology company developing cancer metabolism-based therapies that are intended to be broadly effective across …
Starbucks Financial Statements, Option Care Infusion Pharmacy, What Does Edi Stand For Equality, Mode Of Occurrence Of Subsurface Water, In The 2008 Election Quizlet, Kingdom Come Deliverance Ancient Map 2, Crystal Glycerine Soap Bars, Chanticleer Pear Tree Colorado, Downtown Radio Fm Frequency Belfast, Stock Associate Hiring Near Me, Syngene International Limited Salary,